Overview
Meng-yao Lu practices in Taiwan. Lu is rated as an Advanced expert by MediFind in the treatment of Hemolytic Anemia. Their top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Beta Thalassemia, Bone Marrow Transplant, and Splenectomy.
Their clinical research consists of co-authoring 87 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 15 articles in the study of Hemolytic Anemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- AnemiaLu isAdvanced. Learn about Anemia.
- Beta ThalassemiaLu isAdvanced. Learn about Beta Thalassemia.
- Congenital Hemolytic Anemia
- Embryonal Tumor with Multilayered Rosettes
- Familial Wilms Tumor 2
- Experienced
- Acute Myeloid Leukemia (AML)
- Adult T-Cell LeukemiaLu isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisLu isExperienced. Learn about Agranulocytosis.
- Alpha ThalassemiaLu isExperienced. Learn about Alpha Thalassemia.
- Anaplastic Large Cell Lymphoma
- Aplastic AnemiaLu isExperienced. Learn about Aplastic Anemia.